ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

New Drugs And Older Ones In New Uses Show Progress Against Several Cancers

April 25, 2008

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

December 26, 2003

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

In Brief: Senate Committee Confirms Varmus; Albertini Directs Vermont Cancer Center

November 19, 1993

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988

Major League Baseball Begins Struggle to Eject Ever-Present Smokeless Tobacco Forom The Sport

April 12, 1991